跳至主要内容

Estimating Benefits from Immunesuppressive Treatment in Diffuse Cutaneous Systemic Sclerosis: Data from the Canadian Scleroderma Research Group

Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51274#.VGGiqmfHRK0

Objective: To determine the efficacy of immunesuppressive treatment over 1 year in early diffuse cutaneous systemic sclerosis (dcSSc). Methods: dcSSc patients with less than 3 years disease duration and at least one year of data enrolled in the CSRG database were included. Regression analyses for achieving at least minimal important differences (MID) for 5 outcomes over one year were done to determine baseline predictors of change and if immunesuppressive treatment yielded the attainment of the MID. Results: 124 patients (mean age 52.3 years; 79.2% female) were included. Variables associated with MID at one year were often the baseline variable and for some outcomes, age, sex, smoking, restrictive lung disease and treatment type. Treatment with immunesuppressive was not found to be associated with achieving MIDs in multivariate analyses. Conclusion: Treatment was associated with achieving a MID change at 1 year using univariate statistics, but not in multivariate models. These observational data do not support improvement with immunesuppressives over one year but there could be confounding or biases comparing with those prescribed immunesuppressives vs. those who don’t.
Cite this paper
Choy, T. , Baron, M. and Pope, J. (2014) Estimating Benefits from Immunesuppressive Treatment in Diffuse Cutaneous Systemic Sclerosis: Data from the Canadian Scleroderma Research Group. Open Journal of Rheumatology and Autoimmune Diseases, 4, 248-253. doi: 10.4236/ojra.2014.44034. 
 

[1] Merkel, P.A., Silliman, N.P., Clements, P.J., Denton, C.P., Furst, D.E., Mayes, M.D., et al. (2012) Patterns and Predictors of Change in Outcome Measures in Clinical Trials in Scleroderma: An Individual Patient Meta-Analysis of 629 Subjects with Diffuse Cutaneous Systemic Sclerosis. Arthritis & Rheumatism, 64, 3420-3429.
http://dx.doi.org/10.1002/art.34427
[2] Hudson, M., Steele, R., Lu, Y., Thombs, B.D., Panopalis, P., Baron, M., et al. (2009) Clinical Correlates of Self-Reported Physical Health Status in Systemic Sclerosis. The Journal of Rheumatology, 36, 1226-1229.
http://dx.doi.org/10.3899/jrheum.081057
[3] Pope, J. (2011) Measures of Systemic Sclerosis (Scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician-and Patient-Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler’s Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud’s Condition Score (RCS). Arthritis Care & Research (Hoboken), 63, S98-S111.
[4] Beaton, D.E., Boers, M. and Wells, G.A. (2002) Many Faces of the Minimal Clinically Important Difference (MCID): A Literature Review and Directions for Future Research. Current Opinion in Rheumatology, 14, 109-114.
http://dx.doi.org/10.1097/00002281-200203000-00006
[5] Khanna, D., Furst, D.E., Hays, R.D., Park, G.S., Wong, W.K., Seibold, J.R., et al. (2006) Minimally Important Difference in Diffuse Systemic Sclerosis: Results from the D-Penicillamine Study. Annals of the Rheumatic Diseases, 65, 1325-1329.
http://dx.doi.org/10.1136/ard.2005.050187
[6] Sekhon, S. and Pope, J., Canadian Scleroderma Research Group and Baron M. (2010) The Minimally Important Difference in Clinical Practice for Patient-Centered Outcomes Including Health Assessment Questionnaire, Fatigue, Pain, Sleep, Global Visual Analog Scale, and SF-36 in Scleroderma. The Journal of Rheumatology, 37, 591-598.
http://dx.doi.org/10.3899/jrheum.090375
[7] Lawrence, E., Pope, J., Al-Zahraly, Z., Lalani, S. and Baron, M. (2009) The Relationship between Changes in Self-Reported Disability (Measured by the Health Assessment Questionnaire—HAQ) in Scleroderma and Improvement of Disease Status in Clinical Practice. Clinical and Experimental Rheumatology, 27, 32-37.
[8] Khanna, D., Yan, X., Tashkin, D.P., Furst, D.E., Elashoff, R., Roth, M.D., et al. (2007) Impact of Oral Cyclophosphamide on Health-Related Quality of Life in Patients with Active Scleroderma Lung Disease: Results from the Scleroderma Lung Study. Arthritis & Rheumatism, 56, 1676-1684.
http://dx.doi.org/10.1002/art.22580
[9] Soliman, M.M., Hyrich, K.L., Lunt, M., Watson, K.D., Symmons, D.P., Ashcroft, D.M., et al. (2012) Effectiveness of Rituximab in Patients with Rheumatoid Arthritis: Observational Study from the British Society for Rheumatology Biologics Register. The Journal of Rheumatology, 39, 240-246.
http://dx.doi.org/10.3899/jrheum.110610
[10] Jordan, S., Distler, J.H., Maurer, B., Huscher, D., van Laar, J.M., Allanore, Y., et al. (2014) Effects and Safety of Rituximab in Systemic Sclerosis: An Analysis from the European Scleroderma Trial and Research (EUSTAR) Group. Annals of the Rheumatic Diseases, Published Online First 17 January 2014.
http://dx.doi.org/10.1136/annrheumdis-2013-204522
[11] Gazi, H., Pope, J., Clements, P., Medsger, T., Martin, R., Kahaleh, B., et al. (2007) Outcome Measurements in Scleroderma. The Journal of Rheumatology, 34, 501-509.                                        eww141111lx
标签：

评论

发表评论

此博客中的热门博文

Does Immigration Promote the Investment of the Monopolistic Firm?

In the present paper, we examine the effect of increasing uncertainty of immigrants’ growth on the optimal timing of investment of a firm that has a monopolistic power over the labor market. It is revealed that when the uncertainty of immigrants’ growth is more than a threshold level, increasing uncertainty of immigrants’ growth accelerates the optimal timing of firms’ investment and enhances the economic growth, even if the uncertainty of immigrants’ growth is formulated by the geometric Brownian motion, which is in sharp contrast to the standard result that an increase in the uncertainty postpones the optimal timing. With an increase in the immigrants over the past ten years, workforces in the host countries have been growing significantly to the extent that the immigrants represent 70% of the increase in the workforce in Europe, and 47% in the United States as OECD indicates. In the present paper, we attempted to investigate the effect of increased uncertainty caused by the growi...
发表评论
阅读全文

Education Policy Implementation: A Mechanism for Enhancing Primary Education Development in Zanzibar

Education is one of the fundamental rights of individuals; therefore, the government of a country needs to develop and strengthen educational policy and quality as well as to ensure that everyone has equal access to basic education. The improvement of access and quality of education in the world is becoming as an essential factor in development, whereas the basic education (primary school), is acknowledged as a foundation of the higher educational development for every country. To fulfill this goal, governments introduce several policies and procedures; however, it requires some reforms and participation from the politician, policymakers, and other stakeholders to re-examine educational policy so that it can lead to multiplication and betterment of the reforms. Educational reforms actually focus on accountability. A positive educational development and reform is very challenging and needs more effort and strategy on how to use and utilize the resources effectively as such it can achie...
发表评论
阅读全文